2021 annual financial data
NovoCure 2021 Operating margin
Direct answer
Operating margin was -8.29%.
Operating income was -44,333,000 USD and net income was -58,351,000 USD.
Operating cash flow was 82,756,000 USD.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 535,031,000 USD
- Operating income
- -44,333,000 USD
- Net income
- -58,351,000 USD
- Operating cash flow
- 82,756,000 USD